Effect of Tranexamic Acid on Bleeding in Cardiac Surgery
Official title: The Dose Effect of Activated Clotting Time and Tranexamic Acid on Bleeding in Adult Cardiac Surgery
Run by Taichung Veterans General Hospital · NCT06109155 · Data updated 2026-11-12
This study is testing how different doses of tranexamic acid can help reduce bleeding and the need for blood transfusions in adults having heart surgery.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Taichung Veterans General Hospital Academic / other |
| Locations | 2 sites (Taichung and 1 other locations) |
| Status | Recruiting |
| Started | February 8, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | February 21, 2024 |
| Trial ID | NCT06109155 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults scheduled for cardiac surgery requiring cardiopulmonary bypass.
✕Probably not a fit
Patients who are pregnant, undergoing emergency procedures, or have severe comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the impact of different doses of tranexamic acid and activated clotting time (ACT) levels on bleeding and blood transfusion requirements in adult patients undergoing cardiac surgery. Participants will be divided into four groups based on their tranexamic acid dosage and ACT levels during surgery. The primary outcome measured will be the volume of postoperative bleeding within 24 hours. The study aims to enhance understanding of pharmacological management during cardiac procedures.
Why it matters
Potential benefit: If successful, this study could lead to reduced bleeding and blood transfusion needs in cardiac surgery patients.
How similar studies have gone: Previous studies have shown promising results with tranexamic acid in reducing bleeding in surgical settings, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult, cardiac surgery with cardiopulmonary bypass Exclusion Criteria: * pregnant * emergency procedure * immune compromised * aortic surgery * end-stage renal disease * liver disease * critical status * incomplete clinical data
Where it's running
-
Taichung Veterans General Hospital
Taichung, Taiwan Recruiting -
Taichung Veterans General hospital
Taichung, Taiwan Recruiting
Study contacts
- Study coordinator: Yung-Szu Wu, MD
- Email: adconvert98@gmail.com
- Phone: 0423592525
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimized Flow for Obese Patients Undergoing Heart Surgery
In this study, researchers will test whether using ideal body weight to set cardiopulmonary bypass flow during heart surgery helps obese adults see fewer transfusions and related complications.
-
LMWH for Neonatal Outcomes in Isolated Oligohydramnios
This trial tests whether adding a low-molecular-weight heparin shot to standard care helps babies born after oligohydramnios have better outcomes.
-
Integrated intraoperative hemodynamic monitoring during cardiac surgery with CPB
This pilot study tests a single-dashboard monitoring system to see if it can capture heart and tissue perfusion data during elective cardiac surgery with bypass in adults without changing patient care.
-
Preventive Narrative Exposure for PTSD After Cardiac Surgery in the ICU
In adults having cardiopulmonary bypass heart surgery, this trial tests whether an ICU-based narrative exposure intervention helps prevent posttraumatic stress symptoms compared with standard care.
-
Impact of cardiopulmonary bypass on platelet lipids and bleeding after cardiac surgery
This study tests how CPB changes platelet lipid metabolism and procoagulant platelets to see if these changes relate to inflammation and bleeding after cardiac surgery.
-
Transcutaneous auricular vagus nerve stimulation to prevent kidney injury after heart surgery
This trial tests whether applying a non-invasive ear stimulation (taVNS) around the time of elective heart surgery can help prevent acute kidney injury in adults undergoing cardiopulmonary bypass.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.